Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-23-010132

Chief Financial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Burrell Terry-Ann Chief Financial Officer 2023-03-31 Grant or award +20,000 51,277 D
Derivatives
Burrell Terry-Ann Chief Financial Officer 2023-01-31 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X04/doc4.xml…